-
Domestic new drug research and development is in full swing, and this issue is gradually becoming the focus of pharmaceutical companies
Time of Update: 2023-01-01
Domestic new drug research and development is hot, this problem has become the focus of pharmaceutical companies (Image source: Pharmaceutical Network) On November 16, Hengrui Pharmaceutical also announced that 3 drugs have obtained clinical trial approval notices and will carry out clinical trials in the near future.
-
Multilane launches an automated test system for active fiber optic cable production
Time of Update: 2022-11-17
The system is said to be simple to use, and can simultaneously perform bit error rate and eye diagram testing of 8 channels of AOC.
The system is said to be simple to use, and can simultaneously perform bit error rate and eye diagram testing of 8 channels of AOC.
-
The main body of the world's largest single caprolactone project was capped
Time of Update: 2022-10-31
On October 23, the main project of Hunan Juren Chemical 50,000 tons/year green biodegradable material caprolactone project was successfully capped, and the project construction entered the fast lane safely and smoothly.
-
Chemchemie provides details on chemical reagent CAS:10556-88-4
Time of Update: 2022-10-03
, Ltd. shop Please click here to enter Xi'an Kaixin Biotechnology Co.
, Ltd. shop Please click here to enter Xi'an Kaixin Biotechnology Co.
: 103796-12-9Benzenesulfonamide, 4-amino-N, N-dimethyl-3-nitro-CAS No.
: 103796-12-9Benzenesulfonamide, 4-amino-N, N-dimethyl-3-nitro-CAS No.
: 103796-12-9Benzenesulfonamide, 4-amino-N, N-dimethyl-3-nitro-CAS No.
-
With low clinical trial success rate and low use efficiency, how to break through the bottleneck of "double low" new drug research and development
Time of Update: 2022-09-30
(Image source: pharmaceutical network) New drug research and development is facing a "double low" bottleneck In terms of drug clinical trials, with the continuous increase in R&D investment of domestic pharmaceutical companies, although there are many candidates for clinical trials, the proportion of candidates who can survive to successful approval for listing is not large.
-
tna launches a fully integrated data management tool that provides manufacturers with all availability
Time of Update: 2022-09-25
tna introduces fully integrated data management tools that give manufacturers the ultimate visibility into all production processesQingdao, China, October 30, 2018 – tna today launches tnaintelli-sys iPS3, a fully integrated and high-performance data collection and reporting tool that provides manufacturers with unprecedented insight into all their production processes.
-
Glass bottle cold and thermal shock strength meter - recommended
Time of Update: 2022-09-21
Glass bottle cold and thermal shock strength meter - recommended first we to understand what is thermal shock, thermal shock refers to due to sharp heating or cooling, so that the object in a short pe
-
Shanghai will accelerate the listing of natural gas and other energy varieties
Time of Update: 2022-09-06
Fang Xinghai, vice chairman of the China Securities Regulatory Commission, said: "The CSRC will take the opportunity of improving the listing mechanism of futures and options varieties to promote the listing of varieties in a safe and orderly manner and further enrich and improve the variety system.
-
Precise management of areas with different hygiene levels
Time of Update: 2022-09-01
Noodle punching room: a lot of materials are used, and water or ice water is used during the dough punching process, the whole area will be relatively humid, so it is particularly important to clean, disinfect and supervise inspection after the end of daily production, so as to avoid hygienic dead corners.
-
Greater importance of freshwater aquaculture in global fish supply
Time of Update: 2022-09-01
(Source: China Fisheries News) "China Food News" (06 edition on March 15, 2022) (Editor-in-charge: Wang Jiayi) Aquaculture and aquaculture have made great contributions in ensuring global food security, providing essential nutritional support for human beings, and reducing greenhouse gas emissions from global food production, making them a research hotspot in the current international academic community .
-
Kasai Bio: Bio-based polyamide products are used in many fields
Time of Update: 2022-08-26
Synthetic biology industry has significant opportunitiesSynthetic biology industry has significant opportunities"Carbon neutrality" is a hot topic at this conference, and as an important achievement of synthetic biology, bio-based materials not only do not increase carbon emissions, but are also "carbon negative" materials .
-
Polyurethane recycling
Time of Update: 2022-08-18
The representative of green new energy-saving building materials Because the products produced have many advantages such as light weight, environmental protection, heat preservation, sound insulation, fire prevention, and no radioactivity, they have been used in Beijing's tallest building "China Zun", Beijing's new airport and Beijing city sub-center construction related projects.
-
"Strong expectations" against "weak reality" coking coal hit a new high in March
Time of Update: 2022-03-07
Coking coal 'weak reality' spot price under pressure Cao Ying, chief black analyst at SDIC Anxin Futures, pointed out that the overall coking coal market is expected to be oversupplied in February, domestic coking coal mines may experience pressure on sales and accumulation, and the current downstream demand performance will remain at a low level, and there will be no obvious get better .
-
[Plastic] The sun umbrella of Qingdao International Sailing Week was actually made from recycled cola plastic bottles
Time of Update: 2022-01-14
It turns out that these sun umbrellas are all remanufactured from recycled old plastic bottles.
To make a sun umbrella, you can consume 17 old plastic bottles and realize the recycling of waste products .
(Keyword: Qingdao Plastic Bottle Recycling)
-
Many pharmaceutical companies have merged and reorganized, and their shares have been frozen
Time of Update: 2021-09-28
M&A integration into keywords According to the acquisition plan announced by Jiangzhong Pharmaceutical, the company intends to acquire 51% of the shares of Hays Pharmaceuticals by way of equity transfer and capital increase.
